Dear readers,
AstraZeneca, one of the world’s leading pharmaceuticals firms, recently gained a new level of public interest and importance as it helped produce vaccines to combat COVID-19.
In this case study, Maggie Spong, AstraZeneca’s vice president talent acquisition, explains how her time met unique staffing challenges – and how they have used this extraordinary situation as an opportunity to promote company diversity.
Have a view on the matter? Join our exclusive LinkedIn group and discuss with fellow leaders.
